Skip to main content

Six-minute walk test: prognostic value and effects of nebivolol versus placebo in elderly patients with heart failure from the SENIORS trial

Abstract

Background

There is limited information about the 6-min walk test (6MWT) in elderly patients with heart failure. We evaluated 6MWT and the effect of nebivolol on 6MWT from the SENIORS trial.

Methods and results

The SENIORS trial evaluated nebivolol versus placebo on death and hospitalisation in patients aged ≥ 70 years with heart failure. A total of 1982 patients undertook a 6MWT at baseline and 1716 patients at 6 months. Patients were divided into tertiles (≤ 200 m, 201 to ≤ 300 m and > 300 m) and to change in distance walked between baseline and 6 months (< 0 m, 0 to < 30 m and ≥ 30 m). The primary outcome was all-cause mortality and cardiovascular hospital admission. Secondary endpoint was all-cause mortality. Baseline walk distance of ≤ 200 m incurred a greater risk of the primary and secondary outcomes (HR 1.41, CI 95% 1.17–1.69, p < 0.001) and (HR 1.37, CI 95% 1.05–1.78, p = 0.019). A decline in walk distance over 6 months was associated with increased risk of clinical events. Nebivolol had no influence on change in walk distance over 6 months.

Conclusions

The 6MWT has prognostic utility in elderly patients. Those who walked less than 200 m were at highest risk. Nebivolol had no effect on 6MWT.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Guha K, McDonagh T (2013) Heart failure epidemiology: European perspective. Curr Cardiol Rev 9(2):123–127

    CAS  Article  Google Scholar 

  2. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP, ADHERE Scientific Advisory Committee and Investigators (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149(2):209–216

    Article  Google Scholar 

  3. Ingle L, Cleland JG, Clark AL (2014a) The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure. Biomed Res Int 2014:505969. https://doi.org/10.1155/2014/505969

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ingle L, Cleland JG, Clark AL (2014b) The relation between repeated 6-minute walk test performance and outcome in patients with chronic heart failure. Ann Phys Rehabil Med 57(4):244–253

    CAS  Article  Google Scholar 

  5. Forman DE, Fleg JL, Kitzman DW, Brawner CA, Swank AM, McKelvie RS, Clare RM, Ellis SJ, Dunlap ME, Bittner V (2012) 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol 60(25):2653–2661

    Article  Google Scholar 

  6. Cowie MR, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Suresh V, Sutton GC (1999) Incidence and aetiology of heart failure; a population-based study. Eur Heart J 20(6):421–428

    CAS  Article  Google Scholar 

  7. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. New Eng J Med 355(3):251–259

    CAS  Article  Google Scholar 

  8. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG (2005) Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 26(8):778–793

    CAS  Article  Google Scholar 

  9. Conraads VM, Metra M, Kamp O, De Keulenaer GW, Pieske B, Zamorano J, Vardas PE, Böhm M, Dei Cas L (2012) Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail 14(2):219–225

    CAS  Article  Google Scholar 

  10. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215–225

    CAS  Article  Google Scholar 

  11. Cohen-Solal A, Kotecha D, van Veldhuisen DJ, Babalis D, Böhm M, Coats AJ, Roughton M, Poole-Wilson P, Tavazzi L, Flather M, SENIORS Investigators (2009) Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial. Eur J Heart Fail 11:872–880

    CAS  Article  Google Scholar 

  12. van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, on behalf of the SENIORS Investigators (2009) Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction. J Am Coll Cardiol 53:2150–2158

    Article  Google Scholar 

  13. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111

    Article  Google Scholar 

  14. Manzano L, Babalis D, Roughton M, Shibata M, Anker SD, Ghio S, Veldhuisen DJ, Cohen-Solal A, Coats AJ, Poole-Wilson P, Flather MD (2011) Predictors of clinical outcomes in elderly patients with heart failure. Eur J Heart Fail 13(5):528–536

    Article  Google Scholar 

  15. Rubim VS, Drumond Neto C, Romeo JL, Montera MW (2006) Prognostic value of the six-minute walk test in heart failure. Arq Bras Cardiol 86(2):120–125

    Article  Google Scholar 

  16. Opasich C, Pinna GD, Mazza A, Febo O, Riccardi R, Riccardi PG, Capomolla S, Forni G, Cobelli F, Tavazzi L (2001) Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J 22(6):488–496

    CAS  Article  Google Scholar 

  17. Arslan S, Erol MK, Gundogdu F, Sevimli S, Aksakal E, Senocak H, Alp N (2007) Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J 34(2):166–169

    PubMed  PubMed Central  Google Scholar 

  18. Roul G, German P, Bareiss P (1998) Does the 6 minute walk test predict the prognosis in patients with NYHA class II and III heart failure? Am Heart J 136:449–457

    CAS  Article  Google Scholar 

  19. Reibis RK, Treszl A, Wegscheider K, Ehrlich B, Dissmann R, Völler H (2010) Exercise capacity is the most powerful predictor of 2-year mortality in patients with left ventricular systolic dysfunction. Herz 35(2):104–110

    Article  Google Scholar 

  20. Wegrzynowska-Teodorczyk K, Rudzinska E, Lazorczyk M, Nowakowska K, Banasiak W, Ponikowski P, Wozniewski M, Jankowska EA (2013) Distance covered during a six-minute walk test predicts long-term cardiovascular mortality and hospitalisation rates in men with systolic heart failure: an observational study. J Physiother 59(3):177–187

    Article  Google Scholar 

  21. Rostagno C, Olivo G, Comeglio M, Boddi V, Banchelli M, Galanti G, Gensini GF (2003) Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail 5(3):247–252

    Article  Google Scholar 

  22. Lucas C, Stevenson LW, Johnson W, Hartley H, Hamilton MA, Walden J, Lem V, Eagen-Bengsten E (1999) The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J 138(4):618–624

    CAS  Article  Google Scholar 

  23. Ingle L, Rigby AS, Carroll S, Butterly R, King RF, Cooke CB, Cleland JG, Clark AL (2007) Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J 28:560–568

    Article  Google Scholar 

  24. Grewal J, McCully RB, Kane GC, Lam C, Pellikka PA (2009) Left ventricular function and exercise capacity. JAMA 301(3):286–294

    CAS  Article  Google Scholar 

  25. Fontes-Carvalho R, Sampaio F, Teixeira M, Rocha-Gonçalves F, Gama V, Azevedo A, Leite-Moreira A (2015) Left ventricular diastolic dysfunction and E/E′ ratio as the strongest echocardiographic predictors of reduced exercise capacity after acute myocardial infarction. Clin Cardiol 38(4):222–229

    Article  Google Scholar 

  26. Wenger NK (1988) Left ventricular dysfunction, exercise capacity and activity recommendations. Eur Heart J 9(suppl F):63–66

    Article  Google Scholar 

  27. Guazzi M, Dickstein K, Vicenzi M, Ross A (2009) Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights. Circ Heart Fail 2:549–555

    Article  Google Scholar 

  28. Ferreira JP, Metra M, Anker SD, Dickstein K, Lang CC, Samani NJ et al (2019) Clinical correlates and outcome associated with changes in 6-minute walk distance in patients with heart failure: findings from the BIOSTAT-CHF study. Eur J Heart Fail 21:218–226

    CAS  Article  Google Scholar 

  29. Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, Newman AB (2003) The 6-min walk test: a quick measure of functional status in elderly adults. Chest 123(2):387–398

    Article  Google Scholar 

  30. Passantino A, Lagioia R, Mastropasqua F, Scrutinio D (2006) Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice. J Am Coll Cardiol 48(1):99–105

    Article  Google Scholar 

  31. Shah MR, Hasselblad V, Gheorghiade M, Adams KF, Swedberg K, Califf RM, O’Connor CM (2001) Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or non-ischemic cardiomyopathy. Am J Cardiol 88(9):987–993

    CAS  Article  Google Scholar 

  32. Linssen GCM, Veenis JF, Kleberger A, Grosfield MJW, Viergever EP, van Dalen BM, de Valk-Bedijin W, Langerveld J, Brunner-La Rocca HP, Hoes AW, Brugts JJ (2020) Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF. Clin Res Cardiol. https://doi.org/10.1007/s00392-020-01607-y ((Epub ahead of print, PMID: 32030498))

    Article  PubMed  Google Scholar 

  33. Bekfani T, Pellicori P, Morris D, Ebner N, Valentova M, Sandek A, Doehner W, Cleland JG, Lainscak M, Shulze PC, Anker SD, von Haehling S (2019) Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. Clin Res Cardiol 108:203–211

    CAS  Article  Google Scholar 

  34. Radenovic S, Loncar G, Busjahn A, Apostolovic S, Zdravkovic M, Karlicic V, Veskovic J, Tahirovic E, Butler J, Düngen HD (2018) Systemic inflammation and functional capacity in elderly heart failure patients. Clin Res Cardiol 107:362–367

    Article  Google Scholar 

Download references

Funding

The original SENIORS trial was sponsored by Menarini Research, Italy. The funding source had no role in the design, analysis or interpretation of the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcelo C. Shibata.

Ethics declarations

Conflict of interest

None to declare for this analysis.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shibata, M.C., Curl-Roper, J., Van Veldhuisen, D.J. et al. Six-minute walk test: prognostic value and effects of nebivolol versus placebo in elderly patients with heart failure from the SENIORS trial. Clin Res Cardiol 110, 1193–1201 (2021). https://doi.org/10.1007/s00392-020-01768-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-020-01768-w

Keywords

  • Heart failure
  • Six-minute walk test
  • Elderly
  • Prognosis